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ABSTRACT 
Introduction 
Colorectal cancer is the third most common cancer worldwide, with nearly 1.4 million new cases annually, of which 
about one third suffer from rectal cancer. Laparoscopic surgery has in several surgical fields shown faster recovery, 
shorter hospital stay, and less pain than open surgery. In rectal cancer surgery firm evidence is lacking regarding 
oncological safety. Moreover, patient-reported Health Related Quality of Life (HRQL) has become an important 
outcome in clinical trials, complementing clinically driven endpoints. 
Aim 
The aim of this thesis was to assess if laparoscopic rectal cancer surgery is non-inferior to open surgery in terms of loco-
regional recurrence, disease specific and overall survival, as well as to compare the outcome regarding health related 
quality of life and genitourinary dysfunction. We also analysed if there are factors that determine global quality of life. 
Patients and method 
The four papers were analysed within the only large randomised international multicentre trial comparing laparoscopic 
and open surgery for rectal cancer – the COLOR II trial - an open label non-inferiority trial. Between 2004-2010, 1044 
patients from 30 centres in 8 countries were included. The HRQL sub-study was optional and included 385 patients. 
Results 
In paper I, the primary outcome in COLOR II showed that laparoscopic surgery was non-inferior to open surgery with a 
loco-regional recurrence rate of 5% in both groups with a difference of 0% (90% CI of -2.6 to 2.6). In paper II and III we 
showed that there were no differences in HRQL and genitourinary dysfunction between the surgical techniques. In paper 
IV we discovered pain and fatigue as possible important factors of global quality of life. 
Conclusion 
The overall conclusion was that laparoscopic rectal cancer surgery is non inferior to open surgery in rectal cancer in 
terms of oncological safety. Based on earlier results showing benefits of laparoscopic rectal resection, now is the time to 
widely implement the technique. 
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